ROBIN L. SMITH

Corporate Board Profile

Tech Score: 0/100

Emmaus Life Sciences, Inc.

Filing Date	Source Excerpt
2015-10-06	Robin L. Smith, MD joined our Board of Directors as its Chairman on August 20, 2015. Dr. Smith is currently also the Chairman of the Board of Directors of Caladrius Biosciences (formerly NeoStem) (NASDAQ:CLBS), an emerging cellular therapy business, was Executive Chairman of NeoStem from January 2015 through June 2015 after having previously served as Chairman and Chief Executive Officer of Caladrius Biosciences from 2006 to 2015. Dr. Smith was selected to serve as our Chairman of the Board of Directors because of her extensive experience in the management, marketing and funding of emerging medical technology companies. The following table below sets forth the membership of each Committee: Robin Smith Chair Governance and Nominations Committee.
2018-11-02	Robin Smith (1) 237,500 Fees Earned or Paid in Cash, 135,040 Option Awards ($), 38,750 Stock Awards ($), Total ($) 411,290

Filing Date

Source Excerpt

2015-10-06

Robin L. Smith, MD joined our Board of Directors as its Chairman on August 20, 2015. Dr. Smith is currently also the Chairman of the Board of Directors of Caladrius Biosciences (formerly NeoStem) (NASDAQ:CLBS), an emerging cellular therapy business, was Executive Chairman of NeoStem from January 2015 through June 2015 after having previously served as Chairman and Chief Executive Officer of Caladrius Biosciences from 2006 to 2015. Dr. Smith was selected to serve as our Chairman of the Board of Directors because of her extensive experience in the management, marketing and funding of emerging medical technology companies. The following table below sets forth the membership of each Committee: Robin Smith Chair Governance and Nominations Committee.

2018-11-02

Robin Smith (1) 237,500 Fees Earned or Paid in Cash, 135,040 Option Awards ($), 38,750 Stock Awards ($), Total ($) 411,290

ROCKWELL MEDICAL, INC.

Filing Date	Source Excerpt
2018-04-30	Dr. Robin L. Smith, age 53, has been a director since June 2016. Dr. Smith currently serves as chairman of the board of directors of MYnd Analytics, Inc.... We believe that Dr. Smith's entrepreneurial skills and her extensive experience serving in executive and board level capacities for various medical enterprises and healthcare-based entities qualify her for service as a director of our Company.
2019-04-30	Dr. Smith, age 54, has been a director since June 2016. She serves on the Audit Committee and is Chairwoman of the Governance and Nominating Committee. 2018 Director Compensation table shows $94,140 fees earned in cash and $99,022 option awards totaling $193,162.

Filing Date

Source Excerpt

2018-04-30

Dr. Robin L. Smith, age 53, has been a director since June 2016. Dr. Smith currently serves as chairman of the board of directors of MYnd Analytics, Inc.... We believe that Dr. Smith's entrepreneurial skills and her extensive experience serving in executive and board level capacities for various medical enterprises and healthcare-based entities qualify her for service as a director of our Company.

2019-04-30

Dr. Smith, age 54, has been a director since June 2016. She serves on the Audit Committee and is Chairwoman of the Governance and Nominating Committee. 2018 Director Compensation table shows $94,140 fees earned in cash and $99,022 option awards totaling $193,162.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22